Coronary artery calcification, intima-media thickness, and ankle-brachial index are complementary stroke predictors

Janine Gronewold1, Marcus Bauer1, Nils Lehmann1

  • 1From the Departments of Neurology (J.G., C.W., D.M.H.) and Cardiology (M.B., A.A.M., H.K., R.E.), University Hospital Essen, Essen, Germany; Institute of Medical Informatics, Biometry, and Epidemiology, University of Duisburg-Essen, Essen, Germany (N.L., S.M., K.-H.J.); and Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany (K.B.).

Stroke
|August 14, 2014
PubMed

Insights

Coronary artery calcification (CAC) and ankle-brachial index (ABI) together improve stroke prediction beyond traditional risk factors. Combining CAC with ABI offers significant stroke risk assessment enhancement.

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research
  • Stroke Prevention

Background:

  • Coronary artery calcification (CAC) is a known stroke predictor.
  • The added value of peripheral atherosclerosis markers, carotid intima-media thickness (CIMT) and ankle-brachial index (ABI), to CAC for stroke prediction was unclear.

Purpose of the Study:

  • To investigate if combining CAC with CIMT and ABI improves stroke risk prediction.
  • To assess the incremental predictive value of these markers beyond established risk factors.

Main Methods:

  • Utilized data from 3289 participants (45-75 years) in the Heinz Nixdorf Recall study.
  • Assessed incident stroke over a 9.0±1.9 year follow-up period.
  • Employed multivariable Cox regression and Harrell's c-statistics to analyze CAC, CIMT, and ABI as stroke predictors.

Main Results:

  • CAC, CIMT, and ABI were independently associated with increased stroke risk.
  • Combining CAC with ABI significantly improved the area under the curve (P=0.047) and reclassification metrics.
  • ABI demonstrated the highest predictive value, while CIMT had the lowest.

Conclusions:

  • CAC, CIMT, and ABI provide complementary information for stroke risk assessment.
  • The combination of CAC and ABI offers enhanced stroke risk prediction, particularly in specific subpopulations.
  • ABI is a valuable, distinctive marker for stroke risk stratification.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
956
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
907
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
756
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
888
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
701